Homologous recombination deficiency in pancreatic cancer: Poly (ADP-ribose) polymerase inhibition, checkpoint inhibition, or a combination of both? Correspondence
| Authors: | Keane, F.; Park, W.; O'Reilly, E. M. |
| Title: | Homologous recombination deficiency in pancreatic cancer: Poly (ADP-ribose) polymerase inhibition, checkpoint inhibition, or a combination of both? |
| Keywords: | phase-ii trial; veliparib |
| Journal Title: | JCO Precision Oncology |
| Volume: | 6 |
| ISSN: | 2473-4284 |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-01-01 |
| Start Page: | e2200141 |
| Language: | English |
| ACCESSION: | WOS:000975488400062 |
| DOI: | 10.1200/po.22.00141 |
| PROVIDER: | wos |
| PUBMED: | 35772046 |
| Notes: | Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work